Priya Sachdeva

Stock Analyst at UBS

(2.56)

# 2,207

Out of 5,149 analysts

6

Total ratings

83.33%

Success rate

19.2%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NPCE NeuroPace	Maintains: Buy	$18 → $22	$13.83	+59.07%	2	Dec 16, 2025
	PEN Penumbra	Maintains: Buy	$330 → $335	$340.16	-1.52%	4	Jul 30, 2025

NeuroPace

Dec 16, 2025

Maintains: Buy

Price Target: $18 → $22

Current: $13.83

Upside: +59.07%

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $340.16

Upside: -1.52%